The Role of Lomefloxacin in the Treatment of Chronic Prostatitis

REFERENCES

• Wenninger K, Heiman GR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic non bacterial prostatitis and its correlates. J Urol 1996; 155: 965–68.
   PubMed Web of Science ®Google Scholar
• Drach GW, Fair WR, Meares EM, Stamey TA. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodinia? J Urol 1978; 120: 226–266.
   Google Scholar
• Meares EM Jr Stamey TA. Bacteriologic localization pat-terns in bacterial prostatitis and urethritis. Invest Urol 1968; 5: 492–518.
   Google Scholar
• Chronic prostatitis workshop, National Institutes of Health, Bethesda, Maryland, 1995; December 7-8.
   Google Scholar
• Brunner H, Weidner W, Schiefer HG. Studies on the roles of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J Infect Dis 1983; 147: 807–13.
   PubMed Web of Science ®Google Scholar
• Krieger JM, Riley DE, Roberts MC, Berger RE. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J Clin Microbiol 1996; 34: 3120–8.
   PubMed Web of Science ®Google Scholar
• Domingue GJ, Human LG, Hellstrom WJG. Hidden microorganisms in “abacterial” prostatitis/prostatosynia [Abstract]. J Urol 1997; 157: 243.
   Google Scholar
• Nickel JC, Downey J, Elark J, Ceri H, Olsson M. Antibiotic pharmacokinetics in the inflamed prostate. J Urol 1995; 153: 527–9.
   PubMed Web of Science ®Google Scholar
• Nickel JC, Olson E, Barabas A, et al. Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol 1990; 66: 47–54.
   PubMedGoogle Scholar
• Nickel JC, Olson E, Costerton JW. Rat model of exper-imental prostatitis. Infection 1991; 19 (Suppl. 3): 126-30.
   Google Scholar
• Nickel JC, Costerton JW. Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate 1993; 23: 107–14.
   PubMed Web of Science ®Google Scholar
• Wedren H, Holm SE, Bergman B. Can decreased phagocytis and killing of autologus Gram positive bacteria explain the finding of Gram positive bacteria in “non-bacterial prostatitis"? Acta Pathol Microbiol Immunol Scand 1987; 95: 75–8.
   Google Scholar
• Huleiel M, Lunefeld E, Levy A, Potashnik G, Glezerman M. Distinct expression levels of cytokines and solu-ble cytokine receptors in seminal plasma of fertile and infertile men. Fertil Steril 1996; 66: 135–8.
   PubMed Web of Science ®Google Scholar
• Zisman A, Zisman E, Lindner A, Velikanov S, Siegel YL, Mozes E. Auto-antibodies to prostate specific antigen in patients with benign prostatic hyperplasia. J Urol 1995; 154: 1052–5.
   PubMed Web of Science ®Google Scholar
• Konen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979; 121: 755–8.
   PubMed Web of Science ®Google Scholar
• Moon TD, Clesan S, Neal DEJr. Prostate specific anti-gen and prostatitis II. PSA production and release kinetics in vitro. Prostate 1992; 20: 113–6.
   Google Scholar
• Neal DE Jr, Clesan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis I. Effect of prostatitis on serum PSA in the human and non human primate. Prostate 1992; 20: 105–11.
   Google Scholar
• Alexander RB, Brady F, Pomich S. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins in men with a history of prostatitis. J Urol 1997; 50: 893–9.
   Web of Science ®Google Scholar
• Pacheco-Rupil B, Depianta-Depaoli M, Casadio B. Experimental autoimmune damage to rat male accessory glands. T cell requirement in adoptive transfer of specific tis-sue damage. Am J Reprod Immunol 1984; 5: 15–9.
   Google Scholar
• Dogamala JM, Hanna LD, Heitzfeld CL et al. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J Medic Chem 1986; 29: 394–6.
   Google Scholar
• Wolfson JS, Hooper DC. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989; 2: 378–424.
   PubMed Web of Science ®Google Scholar
• Monk JP, Campoli-Richards DM. Ofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1987; 33: 346–91.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Katawabata T, Itoh T. Mechanism of renal excretion of NY-198, a new pyridonecarboxylic acids antimicrobial agent, in rabbits and dogs. Chemotherapy 1988; 36 (Suppl, 2, Pt 2): 645-8.
   Google Scholar
• Morse IS. Pharmacokinetics and safety of single oral doses of lomefloxacin. Biopharmaceut Drug Disposition1990; 11: 543–51.
   PubMed Web of Science ®Google Scholar
• Russel D. A multinational study of lomefloxacin vs amoxicillin in the treatment of acute exacerbation of chronic bronchitis (Abstract 995). 30th Interscience Congress on Antimicrobial Agents and Chemotherapy, 1990.
   Google Scholar
• Gottfried MH, Ellison WT. Safety and efficacy of lome-floxacin versus cefaclor in the treatment of acute exacerba-tions of chronic bronchitis: Am J Med 1992; 92 (Suppl. 4A): 1085-9.
   Google Scholar
• Pruul H, McDonald PJ. Lomefloxacin-induced modifica-tion of kinetics of growth of Gram-negative bacteria and sus-ceptibility to phagocytic killing by human neutrophils. J Antimicrob Chemother 1990; 25: 91–101.
   PubMed Web of Science ®Google Scholar
• Dubois J, St Pierre C. Antibacterial activity of lomefloxacin against urinary tract, gastrointestinal tract, and respiratory tract pathogens. Curr Therapeut Res 1989; 45: 1000–3.
   Web of Science ®Google Scholar
• Mazzei T, ToneIli F, Novelli A et al. Penetration of cefalotin into suction blister fluid and tissue homogenates in patients undergoing abdominal surgery. Antimicrob Agents Chemother 1994; 38: 2221–3.
   Google Scholar
• Yernault JC, Gris P. A multicenter comparison of the safety and efficacy of lomefloxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis: (Abstract 1306). 30th Interscience Congress on Antimicrobial Agents and Chemotherapy, 1990.
   Google Scholar
• Fair WR, Cordonnier J. The pH of prostatic fluid: a reappraisal and therapeutic implication. J Urol 1978; 120: 695–8.
   PubMed Web of Science ®Google Scholar
• Pfau A, Perlbery S, Shapira A. The pH of the prostatic fluid in health and disease: implications of treatment in chron-ic bacterial prostatitis. J Urol 1978; 119: 384–7.
   PubMed Web of Science ®Google Scholar
• Nickel JC. Experimental prostatitis. In: Prostatitis: etiopathology, diagnosis and therapy. Edited by W. Weidner P.O., Madsen, and H.G. Schiefer. Berlin: Springer-Verlag 1994; 123-32.
   Google Scholar
• Nickel JC, Costerton JW. Coagulase-negative Staphylococcus in chronic prostatitis. J Urol 1992; 147: 398–400.
   PubMed Web of Science ®Google Scholar
• Nickel JC, Bruce AW, Reid G. Pathogenesis, diagnosis and treatment of the prostatitis syndrome. In: Clinical Urology. Edited by R.J. Krane, M.B. Siroky and J.M. Fitzpatrick. Philadelphia: J.B. Lippincott, 1994; 925.
   Google Scholar